Bio-Monitor Tobramycin

FDA 510(k) K780950 · Monitor Science Corp.

Substantially Equivalent

510(k) numberK780950

Submission

Device name
Bio-Monitor Tobramycin
Applicant
Monitor Science Corp.
Mchenry, IL, US
Received
June 9, 1978
Decision date
August 14, 1978
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
DID – Bacillus Subtilis Microbiology Assay, Tobramycin
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3900
Specialty
Clinical Toxicology

Other 510(k)s with product code DID

510(k)DeviceApplicantDecision
K820773Emit-St Urine Cocaine Metabolite AssayDID · Traditional Syva Co.04/08/1982SE
K802038Phenytoin Reagent Test KitDID · Traditional Beckman Instruments, Inc.10/23/1980SE
K780182Tobramycin 125I Ria KitDID · Traditional New England Nuclear02/13/1978SE
K780048Aminoglycoside Test SystemDID · Traditional Nichols Institute Diagnostics01/20/1978SE

More from Nichols Institute Diagnostics

510(k)DeviceDecision
K790580Ria Kit, Prostatic AcidJFH · Traditional 05/25/1979SE
K780951Bio-Monitor GentamicinDKD · Traditional 08/14/1978SE
K780949Bio-Monitor AmikacinKLP · Traditional 08/14/1978SE
K772038Kanamycin RiaKJI · Traditional 01/12/1978SE
K772039Beta-Hcg RiaJHI · Traditional 11/23/1977SE

Questions and answers

When was Bio-Monitor Tobramycin cleared by the FDA?

Bio-Monitor Tobramycin (K780950) received a 510(k) decision of Substantially Equivalent on August 14, 1978, 66 days after the submission was received.

What is the product code of K780950?

The FDA product code is DID – Bacillus Subtilis Microbiology Assay, Tobramycin, a Class II (moderate risk) device regulated under 21 CFR 862.3900.